Cargando…
Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection
Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent. Various CPS conjugated to immunogenic carrier pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390691/ https://www.ncbi.nlm.nih.gov/pubmed/28435909 http://dx.doi.org/10.1016/j.heliyon.2017.e00291 |
_version_ | 1782521512393179136 |
---|---|
author | González-Miro, Majela Rodríguez-Noda, Laura Fariñas-Medina, Mildrey García-Rivera, Dagmar Vérez-Bencomo, Vicente Rehm, Bernd H.A. |
author_facet | González-Miro, Majela Rodríguez-Noda, Laura Fariñas-Medina, Mildrey García-Rivera, Dagmar Vérez-Bencomo, Vicente Rehm, Bernd H.A. |
author_sort | González-Miro, Majela |
collection | PubMed |
description | Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent. Various CPS conjugated to immunogenic carrier proteins are currently licensed and provide protection against the infection caused by the respective serotypes but not against new and emerging virulent serotypes. In this study, we considered the conserved protein antigen PsaA, the pneumococcal surface adhesin A, in order to overcome the limitations of CPS antigens. The PsaA was translationally fused to a polyhydroxybutyrate (PHB) synthase which mediated production of PsaA displayed on PHB inclusions in recombinant Escherichia coli. This suggested that the PsaA fusion to the PHB synthase did not interfere with PHB synthase activity and its ability to mediate formation of nano-sized inclusions composed of a PHB core surrounded by the PHB synthase fused to PsaA. Isolated PHB beads showed a negative surface charge. Transmission electron microscopy analysis suggested that the PsaA fusion to the PHB synthase reduced the size of PHB beads from about 500 nm to 100 nm. The integrity and antigenicity of the fusion protein attached to isolated PHB beads was confirmed by SDS-PAGE, tryptic peptide fingerprinting analysis using MALDI-TOF-MS/MS and immunoblotting using a monoclonal anti-PsaA antibody. Mice immunized with PsaA displaying PHB beads produced high and specific IgG levels dominated by IgG1 isotype. While IgG1 titer were similar between soluble and insoluble PsaA, the IgG2 titers were strongly increased upon vaccination with insoluble PsaA i.e. PsaA displayed on PHB beads. Particulate PsaA-PHB beads elicited IgG antibodies recognizing PsaA in whole cell lysates of seven different serotypes of S. pneumoniae. This study suggested that PHB beads are suitable carriers for PsaA in order to induce a significant and specific Th-2-type immune response. |
format | Online Article Text |
id | pubmed-5390691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-53906912017-04-21 Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection González-Miro, Majela Rodríguez-Noda, Laura Fariñas-Medina, Mildrey García-Rivera, Dagmar Vérez-Bencomo, Vicente Rehm, Bernd H.A. Heliyon Article Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent. Various CPS conjugated to immunogenic carrier proteins are currently licensed and provide protection against the infection caused by the respective serotypes but not against new and emerging virulent serotypes. In this study, we considered the conserved protein antigen PsaA, the pneumococcal surface adhesin A, in order to overcome the limitations of CPS antigens. The PsaA was translationally fused to a polyhydroxybutyrate (PHB) synthase which mediated production of PsaA displayed on PHB inclusions in recombinant Escherichia coli. This suggested that the PsaA fusion to the PHB synthase did not interfere with PHB synthase activity and its ability to mediate formation of nano-sized inclusions composed of a PHB core surrounded by the PHB synthase fused to PsaA. Isolated PHB beads showed a negative surface charge. Transmission electron microscopy analysis suggested that the PsaA fusion to the PHB synthase reduced the size of PHB beads from about 500 nm to 100 nm. The integrity and antigenicity of the fusion protein attached to isolated PHB beads was confirmed by SDS-PAGE, tryptic peptide fingerprinting analysis using MALDI-TOF-MS/MS and immunoblotting using a monoclonal anti-PsaA antibody. Mice immunized with PsaA displaying PHB beads produced high and specific IgG levels dominated by IgG1 isotype. While IgG1 titer were similar between soluble and insoluble PsaA, the IgG2 titers were strongly increased upon vaccination with insoluble PsaA i.e. PsaA displayed on PHB beads. Particulate PsaA-PHB beads elicited IgG antibodies recognizing PsaA in whole cell lysates of seven different serotypes of S. pneumoniae. This study suggested that PHB beads are suitable carriers for PsaA in order to induce a significant and specific Th-2-type immune response. Elsevier 2017-04-11 /pmc/articles/PMC5390691/ /pubmed/28435909 http://dx.doi.org/10.1016/j.heliyon.2017.e00291 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article González-Miro, Majela Rodríguez-Noda, Laura Fariñas-Medina, Mildrey García-Rivera, Dagmar Vérez-Bencomo, Vicente Rehm, Bernd H.A. Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title_full | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title_fullStr | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title_full_unstemmed | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title_short | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
title_sort | self-assembled particulate psaa as vaccine against streptococcus pneumoniae infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390691/ https://www.ncbi.nlm.nih.gov/pubmed/28435909 http://dx.doi.org/10.1016/j.heliyon.2017.e00291 |
work_keys_str_mv | AT gonzalezmiromajela selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection AT rodrigueznodalaura selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection AT farinasmedinamildrey selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection AT garciariveradagmar selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection AT verezbencomovicente selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection AT rehmberndha selfassembledparticulatepsaaasvaccineagainststreptococcuspneumoniaeinfection |